title: Influence of haemochromatosis gene mutations on treatment outcomes in patients with hepatitis C.
authors.forename: B A
authors.initials: BA
authors.lastname: Chapman
authors.forename: M J
authors.initials: MJ
authors.lastname: Burt
authors.forename: C M
authors.initials: CM
authors.lastname: Frampton
authors.forename: T M
authors.initials: TM
authors.lastname: Chapman
authors.forename: M R
authors.initials: MR
authors.lastname: Whitehead
authors.forename: J D
authors.initials: JD
authors.lastname: Upton
authors.forename: P M
authors.initials: PM
authors.lastname: George
mesh_terms: D000998:Antiviral Agents / Q000378:metabolism / Q000627:therapeutic use*; D006432:Hemochromatosis / Q000235:genetics* / Q000378:metabolism; D006526:Hepatitis C / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000378:metabolism / Q000627:therapeutic use*; D007501:Iron / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D007501:Iron